Milestone establishes company as clear market leader with first and only commercially available fully integrated multiomic system
Company seeing significant uptake from new customers in pharma, drug discovery, and traditional research institutions
SAN DIEGO, CA. (July 29, 2025) -- Element Biosciences, a company democratizing access to advanced life science solutions, today announced that installations of its flagship AVITI24 5D Multiomic system have surpassed 50 units globally. This milestone represents significant commercial momentum since the system became available in December 2024, establishing Element Biosciences as the clear market leader in integrated multiomic technology, and underpins the company’s growing portfolio of advanced biological solutions.
"Fifty installations of our AVITI24 systems represent something much bigger than market traction. It's proof that the scientific community is ready to embrace a completely new paradigm for scientific innovation and drug discovery.” said Molly He, CEO and co-founder of Element. “Five, ten, fifteen years from now, researchers will look back at traditional multiomic approaches the same way we now view DNA sequencing. AVITI24 is redefining what scientists can achieve in terms of both the pace and scale of scientific discovery in the most efficient manner, bringing true precision medicine within reach.”
This breakthrough technology has resonated strongly with research institutions, pharmaceutical companies, and clinical laboratories worldwide seeking to accelerate scientific and drug discovery research.
"Generating multiomic data often means piecing together results from different assays and samples—each introducing its own technical noise and blind spots. We've seen the limits of this approach in our own work,” said Linda Orzolek, Head of Lab Operations for OMAPiX. “What’s exciting about the AVITI24 is that it changes the way we think about biological complexity. By capturing multiple molecular layers from a single sample, in a spatial context, we’re no longer guessing how things connect—we’re seeing it all come together in one clear view.”
The AVITI24 is the only commercially available zero library prep, fully integrated multiomic system ever developed, delivering researchers five dimensions of insight—capturing RNA, protein, morphology, spatial context, and dynamic response—all from the same sample.
While other companies have announced multiomic offerings, none are expected to match the depth of integration AVITI24 provides. That gives Element a significant head start in delivering scalable, cost-efficient, and truly integrated multiomic workflows in this rapidly growing segment.
About Element Biosciences, Inc.
Element Biosciences is a life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact
Michael Sullivan
Media@elembio.com